# Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

> **NCT02807597** · PHASE1,PHASE2 · TERMINATED · sponsor: **Samuel Achilefu** · enrollment: 9 (actual)

## Conditions studied

- Breast Cancer
- Cancer of the Breast

## Interventions

- **DRUG:** LS301
- **DEVICE:** Cancer Vision Goggles and standard fluorescence imaging systems
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT02807597
- **Lead sponsor:** Samuel Achilefu
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-18
- **Primary completion:** 2022-01-27
- **Final completion:** 2022-01-27
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Before LS301's licensing and reformulation, 9 patients received LS301-HSA (Phase 1a) , but since no patients were recruited (in Phase 1b) before the product expired, this study has been terminated.
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02807597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02807597, "Real-time Intraoperative Breast Cancer Visualization for Margin Assessment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02807597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*